6505--Ranolazine Sustained Action (SA) Tablets
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79725R0036
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA) National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79725R0036 for Ranolazine Sustained Action (SA) Tablets, targeting multiple federal healthcare entities including VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The procurement is unrestricted and will award a single contract to a responsible offeror capable of providing an uninterrupted supply of the specified pharmaceutical product. Offerors must provide exact drug name matching the label and a unique NDC number, with the contractor's label being the only permitted label on the product. The solicitation requires specific packaging standards, including safety-caps capable of conversion, 120cc bottle volume, and precise labeling dimensions. The electronic solicitation will be issued on April 21, 2025, with a tentative closing date of May 6, 2025, and interested parties are advised to continuously monitor SAM.gov for updates and amendments.
The contract will cover a one-year base period with four additional one-year option periods, distributed through VA and DoD Pharmaceutical Prime Vendor Programs. The estimated annual requirements include 229,028 bottles of 500mg Ranolazine SA Tablets and 95,925 bottles of 1000mg Ranolazine SA Tablets, both in 60-count bottles. There are no specific set-aside designations for this procurement, making it open to all qualified vendors. The NAICS code for this opportunity is 325412 (Pharmaceutical Preparation Manufacturing), which provides additional context for potential bidders. Contract Specialist Deb Fassl (Deborah.Fassl@va.gov) is the primary point of contact for questions, and all solicitation documents will be available electronically, with no paper copies being provided. Vendors must carefully review all requirements, particularly the detailed packaging and labeling specifications, to ensure compliance with the solicitation terms.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79725R0036 for an unrestricted procurement for Ranolazine Sustained Action Tablets (SA) Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DoD s respective Pharmaceutical Prime Vendor Programs.
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 - 2, 60 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.
Solicitation # 36E79725R0036 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about April 21, 2025, with a tentative closing date of May 6, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Deb Fassl. Questions can be e-mailed to Deborah.Fassl@va.gov.
The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION
ITEM
DESCRIPTION
PACKAGE SIZE (Tablets per Bottle)
TOTAL ESTIMATED ANNUAL USAGE (Bottles)
1
RANOLAZINE 500MG TAB, SA
60
229,028
2
RANOLAZINE 1000MG TAB, SA
60
95,925
Files
| File | Type | Posted |
|---|---|---|
| 36E79725R0036_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Ranolazine SA Tablets - Radha - 11/20/25 - 11/19/26 | Award Notice | |
| 6505--Ranolazine Sustained Action (SA) Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| Lidocaine 5% patches-request for information | Veterans Integrated Service Network 15 | No set-aside | |
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 | Veterans Integrated Service Network 10 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity